Turn Therapeutics (TTRX) announced the launch of a broad communications initiative, featuring a recurring webinar series for shareholders and a forthcoming Founder Blog authored by patient-turned-founder and CEO, Bradley Burnam. The Founder Blog will publicly share ongoing company updates, research insights, and perspectives on Turn’s growth and innovation. Further details about the blog will be announced later this week. The webinar series will provide live discussion covering ongoing programs, strategic milestones, and upcoming developments. The first live session will take place on Wednesday, October 22, 2025, at 2:00 PM ET via webcast.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TTRX:
- Turn Therapeutics appoints Kester to board of directors
- Turn Therapeutics files to sell 7M shares off common stock for holders
- Turn Therapeutics Inc. Common Stock trading resumes
- Turn Therapeutics Inc. Common Stock trading halted, volatility trading pause
- Turn Therapeutics commences trading on Nasdaq